» Articles » PMID: 32294682

BRAZILIAN SOCIETY OF HEPATOLOGY UPDATED RECOMMENDATIONS FOR DIAGNOSIS AND TREATMENT OF HEPATOCELLULAR CARCINOMA

Abstract

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. The Brazilian Society of Hepatology (SBH) published in 2015 its first recommendations about the management of HCC. Since then, new data have emerged in the literature, prompting the governing board of SBH to sponsor a single-topic meeting in August 2018 in São Paulo. All the invited experts were asked to make a systematic review of the literature reviewing the management of HCC in subjects with cirrhosis. After the meeting, all panelists gathered together for the discussion of the topics and the elaboration of updated recommendations. The text was subsequently submitted for suggestions and approval of all members of the Brazilian Society of Hepatology through its homepage. The present manuscript is the final version of the reviewed manuscript containing the recommendations of SBH.

Citing Articles

International perspectives on LI-RADS.

Kierans A, Aguirre D, Krishan S, Lee J, Ronot M, Wang J Abdom Radiol (NY). 2024; .

PMID: 39699666 DOI: 10.1007/s00261-024-04729-3.


Retrospective analysis of the efficacy and survival associated with cTACE and DEB-TACE in the palliative treatment of hepatocellular carcinoma: experience of a tertiary care hospital in southern Brazil.

Fontana P, Coral G, Horbe A, Jotz R, de Morais B, de Mattos A Radiol Bras. 2024; 57:e20230105.

PMID: 38993962 PMC: 11235059. DOI: 10.1590/0100-3984.2023.0105.


Antiproliferative Activity of -Acylhydrazone Derivative on Hepatocellular Carcinoma Cells Involves Transcriptional Regulation of Genes Required for G2/M Transition.

Andrade A, Pauli F, Pressete C, Zavan B, Hanemann J, Miyazawa M Biomedicines. 2024; 12(4).

PMID: 38672246 PMC: 11048582. DOI: 10.3390/biomedicines12040892.


Results of transarterial chemoembolization of hepatocellular carcinoma as a bridging therapy to liver transplantation.

Jotz R, Horbe A, Coral G, Fontana P, de Morais B, de Mattos A Radiol Bras. 2024; 56(5):235-241.

PMID: 38204906 PMC: 10775808. DOI: 10.1590/0100-3984.2023.0040.


A valuable tool for the treatment of hepatocellular carcinoma.

Penachim T Radiol Bras. 2024; 56(5):VII-VIII.

PMID: 38204902 PMC: 10775809. DOI: 10.1590/0100-3984.2023.56.5e2.